(Q39254961)

10 September 2017

Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy (English)

1 reference

10 September 2017

Tao Li

1

1 reference

10 September 2017

Shengsong Huang

2

1 reference

10 September 2017

Minghua Dong

3

1 reference

10 September 2017

Yaping Gui

4

1 reference

10 September 2017

Denglong Wu

5

1 reference

10 September 2017

22 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

31

1 reference

10 September 2017

8

1 reference

10 September 2017

1539-1545

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Characterization of biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

SUMO: a history of modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Concepts in sumoylation: a decade on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Protein modification by SUMO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Modification in reverse: the SUMO proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

SUMOylation and De-SUMOylation: wrestling with life's processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Differential regulation of sentrinized proteins by a novel sentrin-specific protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Role of desumoylation in the development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Hypoxia signalling in cancer and approaches to enforce tumour regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

Natural history of progression after PSA elevation following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.03.007

10.1016/J.UROLONC.2012.03.007

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference